EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Identification of Somatic and Germline Mutations Influencing Treatment Outcomes and Disease Susceptibility in Tunisian Triple-Negative Breast Cancer Using Next-Generation Sequencing

Asma Mehri, Ahmed Baligh Laaribi, Ichraf Jbir, Emna Chelbi, Beya Chelly, Abir Chaabane, Salwa Nechi, Hadda-Imen Ouzari

British Journal of Biomedical Science · 22.04.2026 · 83

DOI: 10.3389/bjbs.2026.15988 ↗

Kurz gefasst

Fachartikel in der Zeitschrift British Journal of Biomedical Science, online erschienen am 22.04.2026. Verfasst von Asma Mehri und 7 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Microorganisms and Active Biomolecules (LR03ES03), Faculty of Sciences of Tunis, University of Tunis El Manar, Tunis, Tunisia. Hauptthemen laut MEDLINE: Germ-Line Mutation, Triple Negative Breast Neoplasms, Genetic Predisposition to Disease. Die Arbeit nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Triple-negative breast cancer (TNBC) is an aggressive breast cancer subtype characterized by marked molecular heterogeneity and limited targeted therapeutic options. Its incidence is rising in many low- and middle-income countries, where genetic profiling of affected patients remains largely unexplored despite evident clinical disparities. This study aimed to characterize, for the first time in a Tunisian cohort, the spectrum of germline and somatic mutations in TNBC patients and to assess their potential impact on therapeutic response. Targeted next-generation sequencing (NGS) of hotspot regions across 50 cancer-related genes was performed in twelve patients using the AmpliSeq for Illumina Cancer Hotspot Panel v2, applied to both tumor tissues and matched adjacent non-tumoral tissues. Bioinformatics analysis revealed recurrent germline variants present in all samples, notably in TP53 (rs1042522), CSF1R (rs2066933), FGFR3 (rs7688609), RET (rs1800861), KDR (rs7692791), and PDGFRA (rs1873778). In tumor tissues, 32 deleterious somatic variants were detected across 20 oncogenes, with TP53 emerging as the most frequently mutated gene (58%). Distinct mutational patterns were observed in relation to treatment response. Notably, the co-occurrence of AKT1 (rs121434592) and TP53 (rs876660754) was observed in a patient with treatment resistance, whereas an in-frame deletion in NOTCH1 (p.Val1578del) was uniquely detected in patients who subsequently experienced disease recurrence. These findings provide the first comprehensive characterization of germline and somatic alterations in Tunisian TNBC patients, representing a North African cohort. They reveal the heterogeneity of mutation patterns linked to treatment response, and emphasize the importance of genomic profiling into clinical practice and guide personalized therapeutic strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Germ-Line MutationTriple Negative Breast NeoplasmsGenetic Predisposition to DiseaseHumansFemaleHigh-Throughput Nucleotide SequencingTunisiaMiddle AgedAdultTreatment OutcomeTumor Suppressor Protein p53AgedMutation

Stichwörter der Autor:innen

TP53germline variantsnext-generation sequencing (NGS)precision medicinesomatic mutations

Substanzen

Tumor Suppressor Protein p53

Autor:innen und Institutionen

  • Laboratory of Microorganisms and Active Biomolecules (LR03ES03), Faculty of Sciences of Tunis, University of Tunis El Manar, Tunis, Tunisia.
  • Commun Sequencing Unite, Department of Biology, Faculty of Sciences of Tunis, University of Tunis El Manar, Tunis, Tunisia.
  • Faculty of Medicine of Tunis, University of Tunis El Manar, Tunis, Tunisia.
  • Department of General Surgery, University Hospital of Mohamed Taher Maamouri, Nabeul, Tunisia.
  • Department of Pathology, University Hospital of Mohamed Taher Maamouri, Nabeul, Tunisia.

Zitieren

APA

Mehri, A., Laaribi, A. B., Jbir, I., Chelbi, E., Chelly, B., Chaabane, A., Nechi, S., & Ouzari, H. I. (2026). Identification of Somatic and Germline Mutations Influencing Treatment Outcomes and Disease Susceptibility in Tunisian Triple-Negative Breast Cancer Using Next-Generation Sequencing. British Journal of Biomedical Science, 83. https://doi.org/10.3389/bjbs.2026.15988

Vancouver

Mehri A, Laaribi AB, Jbir I, Chelbi E, Chelly B, Chaabane A, et al. Identification of Somatic and Germline Mutations Influencing Treatment Outcomes and Disease Susceptibility in Tunisian Triple-Negative Breast Cancer Using Next-Generation Sequencing. British Journal of Biomedical Science. 2026;83. doi:10.3389/bjbs.2026.15988

BibTeX
@article{Mehri2026,
  author = {Mehri, Asma and Laaribi, Ahmed Baligh and Jbir, Ichraf and Chelbi, Emna and Chelly, Beya and Chaabane, Abir and Nechi, Salwa and Ouzari, Hadda-Imen},
  title = {Identification of Somatic and Germline Mutations Influencing Treatment Outcomes and Disease Susceptibility in Tunisian Triple-Negative Breast Cancer Using Next-Generation Sequencing},
  journal = {British Journal of Biomedical Science},
  year = {2026},
  volume = {83},
  doi = {10.3389/bjbs.2026.15988}
}
Kostenlos starten →